Literature DB >> 17510218

Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species.

Xiao-Bing Zhang1, Jeffrey L Schwartz, R Keith Humphries, Hans-Peter Kiem.   

Abstract

Overexpression of the human HOXB4 has been shown to induce the expansion and self-renewal of murine hematopoietic stem cells. In preparation for clinical studies, we wished to investigate the effects of HOXB4 on cells from other species, in particular preclinical large animals such as dogs and nonhuman primates. Thus, we transduced CD34(+) cells from nonhuman primates, dogs, and humans with a HOXB4-expressing gammaretroviral vector and a yellow fluorescent protein-expressing control vector. Compared with the control vector, HOXB4 overexpression resulted in a much larger increase in colony-forming cells in dog cells (28-fold) compared with human peripheral blood, human cord blood, and baboon cells (two-, four-, and fivefold, respectively). Furthermore, we found that HOXB4 overexpression resulted in immortalization with sustained growth (>12 months) of primitive hematopoietic cells from mice and dogs but not from monkeys and humans. This difference correlated with increased levels of retrovirally overexpressed HOXB4 in dog and mouse cells compared with human and nonhuman primate cells. The immortalized cells did not show any evidence of insertional mutagenesis or chromosomal abnormalities. Competitive congenic transplantation experiments showed that HOXB4-expanded mouse cells engrafted well after 1 or 3 months of expansion, and no leukemia was observed in mice. Our findings suggest that the growth promoting effects of HOXB4 are critically dependent on HOXB4 expression levels and that this can result in important species-specific differences in potency. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510218     DOI: 10.1634/stemcells.2006-0742

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

1.  Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.

Authors:  Korashon L Watts; Colleen Delaney; R Keith Humphries; Irwin D Bernstein; Hans-Peter Kiem
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

Review 2.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

3.  Mapping mouse hemangioblast maturation from headfold stages.

Authors:  Jerry M Rhee; Philip M Iannaccone
Journal:  Dev Biol       Date:  2012-02-24       Impact factor: 3.582

4.  Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation.

Authors:  Alice M S Cheung; Donna Leung; Shabnam Rostamirad; Kiran Dhillon; Paul H Miller; Radina Droumeva; Ryan R Brinkman; Donna Hogge; Denis Claude Roy; Connie J Eaves
Journal:  Blood       Date:  2012-02-28       Impact factor: 22.113

5.  Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells.

Authors:  Ana P Barba-de la Rosa; Erika Briones-Cerecero; Ofelia Lugo-Melchor; Antonio De León-Rodríguez; Leticia Santos; Julio Castelo-Ruelas; Alejandra Valdivia; Patricia Piña; Alicia Chagolla-López; Daniel Hernandez-Cueto; Alejandra Mantilla; Minerva Lazos-Ochoa; Beatriz Gonzalez-Yebra; Mauricio Salcedo
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-27       Impact factor: 4.553

6.  Hematopoietic stem cell expansion facilitates multilineage engraftment in a nonhuman primate cord blood transplantation model.

Authors:  Korashon L Watts; Veronica Nelson; Brent L Wood; Grant D Trobridge; Brian C Beard; R Keith Humphries; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2011-12-08       Impact factor: 3.084

7.  High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.

Authors:  Xiao-Bing Zhang; Brian C Beard; Grant D Trobridge; Brent L Wood; George E Sale; Reeteka Sud; R Keith Humphries; Hans-Peter Kiem
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  TLX1 (HOX11) immortalization of embryonic stem cell-derived and primary murine hematopoietic progenitors.

Authors:  Robert G Hawley; Teresa S Hawley; Alan B Cantor
Journal:  Curr Protoc Stem Cell Biol       Date:  2008-12

9.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

Review 10.  Concise review: next-generation cell therapies to prevent infections in neutropenic patients.

Authors:  Marion E G Brunck; Lars K Nielsen
Journal:  Stem Cells Transl Med       Date:  2014-03-05       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.